BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 7494271)

  • 1. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.
    Liu H; Wu X; Newman M; Shaw GM; Hahn BH; Kappes JC
    J Virol; 1995 Dec; 69(12):7630-8. PubMed ID: 7494271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.
    Liu B; Yu X; Luo K; Yu Y; Yu XF
    J Virol; 2004 Feb; 78(4):2072-81. PubMed ID: 14747572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.
    Sova P; Volsky DJ; Wang L; Chao W
    J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.
    Borman AM; Quillent C; Charneau P; Dauguet C; Clavel F
    J Virol; 1995 Apr; 69(4):2058-67. PubMed ID: 7884851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vif mutations on cell-free infectivity and replication of simian immunodeficiency virus.
    Park IW; Myrick K; Sodroski J
    J Acquir Immune Defic Syndr (1988); 1994 Dec; 7(12):1228-36. PubMed ID: 7965633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells.
    von Schwedler U; Song J; Aiken C; Trono D
    J Virol; 1993 Aug; 67(8):4945-55. PubMed ID: 8331734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis.
    Aiken C; Trono D
    J Virol; 1995 Aug; 69(8):5048-56. PubMed ID: 7541845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of human immunodeficiency virus type 1 Vif particle incorporation.
    Camaur D; Trono D
    J Virol; 1996 Sep; 70(9):6106-11. PubMed ID: 8709234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection.
    Kao S; Akari H; Khan MA; Dettenhofer M; Yu XF; Strebel K
    J Virol; 2003 Jan; 77(2):1131-40. PubMed ID: 12502829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and viral specificities of human immunodeficiency virus type 1 vif protein.
    Madani N; Kabat D
    J Virol; 2000 Jul; 74(13):5982-7. PubMed ID: 10846079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: role of the vif gene in HIV-1 infection kinetics and cytopathicity.
    Sakai K; Ma XY; Gordienko I; Volsky DJ
    J Virol; 1991 Nov; 65(11):5765-73. PubMed ID: 1920615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein.
    Karczewski MK; Strebel K
    J Virol; 1996 Jan; 70(1):494-507. PubMed ID: 8523563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus.
    Chowdhury IH; Chao W; Potash MJ; Sova P; Gendelman HE; Volsky DJ
    J Virol; 1996 Aug; 70(8):5336-45. PubMed ID: 8764044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function.
    Khan MA; Akari H; Kao S; Aberham C; Davis D; Buckler-White A; Strebel K
    J Virol; 2002 Sep; 76(18):9112-23. PubMed ID: 12186895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions.
    Dettenhofer M; Yu XF
    J Virol; 1999 Feb; 73(2):1460-7. PubMed ID: 9882352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Vif in stability of the human immunodeficiency virus type 1 core.
    Ohagen A; Gabuzda D
    J Virol; 2000 Dec; 74(23):11055-66. PubMed ID: 11070000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.
    Wu X; Liu H; Xiao H; Kim J; Seshaiah P; Natsoulis G; Boeke JD; Hahn BH; Kappes JC
    J Virol; 1995 Jun; 69(6):3389-98. PubMed ID: 7745685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions.
    Gaddis NC; Chertova E; Sheehy AM; Henderson LE; Malim MH
    J Virol; 2003 May; 77(10):5810-20. PubMed ID: 12719574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Vif in human immunodeficiency virus type 1 reverse transcription.
    Goncalves J; Korin Y; Zack J; Gabuzda D
    J Virol; 1996 Dec; 70(12):8701-9. PubMed ID: 8970997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vif counteracts a cyclophilin A-imposed inhibition of simian immunodeficiency viruses in human cells.
    Takeuchi H; Buckler-White A; Goila-Gaur R; Miyagi E; Khan MA; Opi S; Kao S; Sokolskaja E; Pertel T; Luban J; Strebel K
    J Virol; 2007 Aug; 81(15):8080-90. PubMed ID: 17522232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.